Cargando…
Breast cancer cells exploit mitophagy to exert therapy resistance
Autores principales: | Hardy, Liana, Frison, Michele, Campanella, Michelangelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865650/ https://www.ncbi.nlm.nih.gov/pubmed/29581824 http://dx.doi.org/10.18632/oncotarget.24533 |
Ejemplares similares
-
Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy
por: Georgakopoulos, Nikolaos D., et al.
Publicado: (2017) -
Common Traits Spark the Mitophagy/Xenophagy Interplay
por: Singh, Aarti, et al.
Publicado: (2018) -
The translocator protein (TSPO) is prodromal to mitophagy loss in neurotoxicity
por: Frison, Michele, et al.
Publicado: (2021) -
Parkin in cancer: Mitophagy-related/unrelated tasks
por: Eid, Nabil, et al.
Publicado: (2017) -
PMI: A ΔΨ(m) Independent Pharmacological Regulator of Mitophagy
por: East, Daniel A., et al.
Publicado: (2014)